Know the Latest About COVID-19 MAbs and Remdesivir
Questions are popping up about changes with COVID-19 monoclonal antibodies (MAbs) and remdesivir.
Treatment. If oral nirmatrelvir/ritonavir (Paxlovid) is not an option, use the IV MAb sotrovimab for mild to moderate COVID-19.
Consider it for OUTpatients positive for COVID-19 who are at high risk of severe illness (diabetes, etc)...regardless of vaccination status.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote